Suchergebnisse - "Haga, Yuki"

PubPharm (97)

1

Increased expression of long non-coding RNA FIRRE promotes hepatocellular carcinoma by HuR-CyclinD1 axis signaling

enthalten in: The Journal of biological chemistry | 2024

von Haga, Y. | Bandyopadhyay, D. | Khatun, M. | +6

2

Hepatitis C virus modified sE2F442NYT as an antigen in candidate vaccine facilitates human immune cell activation

enthalten in: Journal of virology | 2024

von Haga, Y. | Meyer, K. | Sung, M. | +3

3

A Prospective Study Exploring the Safety and Efficacy of Lenvatinib for Patients with Advanced Hepatocellular Carcinoma and High Tumor Burden : The LAUNCH Study

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Kobayashi, K. | Ogasawara, S. | Maruta, S. | +29

4

Analysis of hyperprogressive disease due to atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma

enthalten in: ResearchSquare.com | 2023

von Yumita, S. | Ogasawara, S. | Nakagawa, M. | +36

5

Enhanced metabolism of 2,3',4,4',5-pentachlorobiphenyl (CB118) by bacterial cytochrome P450 monooxygenase mutants of Bacillus megaterium

enthalten in: The Science of the total environment | 2023

von Ishida, Y. | Goto, E. | Haga, Y. | +10

6

Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice

enthalten in: BMC gastroenterology | 2023

von Yumita, S. | Ogasawara, S. | Nakagawa, M. | +36

7

Hyperprogressive disease during atezolizumab plus bevacizumab treatment in patients with advanced hepatocellular carcinoma from Japanese real-world practice

enthalten in: BMC gastroenterology | 2023

von Yumita, S. | Ogasawara, S. | Nakagawa, M. | +36

8

Hepatitis C virus E1 and modified E2 delivered from an mRNA vaccine induces protective immunity

enthalten in: NPJ vaccines | 2023

von Patra, T. | Meyer, K. | Haga, Y. | +3

9

Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real-world practice

enthalten in: Cancer | 2023

von Nakagawa, M. | Inoue, M. | Ogasawara, S. | +38

10

Clinical effects and emerging issues of atezolizumab plus bevacizumab in patients with advanced hepatocellular carcinoma from Japanese real‐world practice

enthalten in: Cancer | 2023

von Nakagawa, M. | Inoue, M. | Ogasawara, S. | +38

1
2
3
4
5
6
7
8
9
10
Nächster »
[10]